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Introduction: Nordic walking, characterized by the use of two walking poles, is becoming increasingly
popular. The aim of this study was to analyze the effects produced by a 12-week Nordic walking training
program on functional abilities and metabolic proﬁles, speciﬁcally walk distance and insulin resistance,
among elderly women.
Methods: The present study included 74 women (68 ± 7 years). The Nordic walking training program of
120 minutes per week was performed for 12 weeks. Before and at the end of the 12-week intervention,
6-minute walking distance (6MWD) and the homeostasis of the model assessment of insulin resistance
(HOMA-IR) were measured.
Results and conclusions: After the 12-week Nordic walking training program, 6MWD increased signiﬁ-
cantly (p < 0.001). HOMA-IR improved signiﬁcantly from a median (interquartile range) of 2.01 (1.31
e2.59) to 1.32 (0.86e2.08) after intervention. Stepwise multiple linear regression analyses for changes in
HOMA-IR showed that changes in the body mass index (BMI; b ¼ 0.255, p ¼ 0.019), triglycerides (TG;
b ¼ 0.266, p ¼ 0.015), and uric acid (b ¼ 0.279, p ¼ 0.009) were independently and signiﬁcantly asso-
ciated with changes in HOMA-IR. The increased 6MWD correlated signiﬁcantly with improved HOMA-IR
in participants with baseline gamma-glutamyl transferase (GGT)  26 IU/L (r ¼ 0.682, p ¼ 0.005), but
not in those with baseline GGT < 26 IU/L (r ¼ 0.127, p ¼ 0.338). Analysis of covariance showed that two
regression lines in each graph were signiﬁcantly different (F ¼ 5.64, p ¼ 0.020). These results suggest that
increased 6MWD predicts improvement in insulin resistance after a 12-week Nordic walking training
program in participants with elevated GGT.
Copyright © 2015, Asia Paciﬁc League of Clinical Gerontology & Geriatrics. Published by Elsevier Taiwan
LLC.  Open access under CC BY-NC-ND license.1. Introduction
Nordic walking is characterized by walking with poles to in-
crease the use of the upper body muscles compared with standard
walking, and is becoming a popular activity in Northern Europe.
Several studies have demonstrated that compared to standard
walking, Nordic walking may lead to greater adaptations in the
cardiovascular and respiratory systems, as well as greater energy
expenditure on both acute and long-term effects of Nordic
walking.1e3 Nordic walking also has positive effects on aerobic
performance, body composition, and the metabolic markers of thedicine, Seiyo Municipal Nomura H
awamoto).
erms of the Creative Commons At
ribution, and reproduction in any
linical Gerontology & Geriatrics. Prisk for cardiovascular disease (CVD). Morgulec-Adamowicz and
colleagues4 advocated in a recent review of scientiﬁc literature
available on Nordic walking, that there are few literatures exam-
ining the beneﬁts of Nordic walking as a potential health inter-
vention in elderly adults.
Insulin resistance plays an important role in the pathogenesis of
incident diabetes, hypertension, dyslipidemia, and CVD.5e7 Alter-
natives have been sought to simplify the measurement of insulin
resistance and one of them includes a homeostatic model assess-
ment of insulin resistance (HOMA-IR), which uses fasting insulin
and glucose levels to calculate insulin resistance.8 In addition, serumospital, 9-53 Nomura, Nomura-cho, Seiyo-city, Ehime 797-1212, Japan.
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Fig. 1. Nordic walking.
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glucose levels,9,10 insulin resistance, and metabolic syndrome.11,12
Thus, we hypothesized that the 12-week Nordic walking training
program might improve functional abilities and metabolic proﬁles,
speciﬁcally walking distance, GGT, and insulin resistance assessed
by HOMA-IR.
The purpose of this study was to evaluate whether a 12-week
Nordic walking training intervention had positive effects on the
metabolic state and physical performance of community-dwelling
elderly people.
2. Methods
2.1. Participants
The present study was designed as part of the Nomura study.9
Participants were selected through a community-based annual
check-up process in a rural town located in Ehime Prefecture, Japan.
The physical activity level of participants, medical history infor-
mation, present conditions, and medications taken were obtained
through the interviewing process. Candidates with CVDs, or any
other major illnesses that could affect the laboratory test results,
were excluded. The participants were 74 women (aged, 68 ± 7
years). This study was approved by the Ethics Committee of Ehime
University Graduate School of Medicine, Ehime, Japan and written
informed consent was obtained from each participant.
2.2. Evaluation of risk factors
Information on demographic characteristics and risk factors
were collected using the participant's clinical ﬁles, at the baseline
level and at the completion of the 12 weeks training. Body mass
index (BMI) was calculated by dividing weight (kg) by the square of
the height (m). We measured blood pressure from the right upper
arm of participants in the sedentary position using an automatic
oscillometric blood pressure recorder, after having the participants
rest for at least 5 minutes. Total cholesterol (T-C), triglycerides (TG),
high-density lipoprotein cholesterol (HDL-C), high sensitivity C-
reactive protein (hsCRP), GGT, uric acid, fasting plasma glucose
(FPG), immunoreactive insulin (IRI), hemoglobin A1c (HbA1c), and
hemoglobin (Hb) were measured during an overnight fast of > 11
hours. Plasma hsCRP concentration was measured using a Behring
BN Ⅱ nephelometer (Dade Behring Inc., Marburg, Germany), and
the inter- and intra-assay coefﬁcient variations were 3.2% and 6.7%,
respectively. Serum GGT concentration was assayed with an auto-
matic analyzer (TBA-c6000, Toshiba, Tokyo, Japan) and this
intraassay-coefﬁcient of variation was 0.87e2.11%. HOMA-IR was
calculated from FPG and IRI levels using the following the formula8:
FPG mg=dLð Þ  IRI mU=mLð Þf g=405 (1)
2.3. Intervention
Participants were required to take part in three instructor-led
sessions lasting 120 minutes per week for 12 weeks. Participants
were issued poles and tutored on the correct technique for using
the equipment during the 1st week, dedicating 120-minute sessions
to the Nordic walking technique (Fig. 1). The pole length used for
the Nordic walk was selected and adjusted to permit a smooth arm
motion, based on the International Nordic Walking Federation
(INWA) formula (0.68  body height cm),13 and to induce a near
right-angle elbow ﬂexion upon pole landing.14 The Nordic walking
program was designed so that the performers could be in the aer-
obic work zone throughout the exercise sessions. Assessment ofpost intervention dependent variables occurred within 1 week of
the ﬁnal walking session. Two participants dropped out as they
were unable to commit to the study, and 18 participants did not
report for the postintervention testing due to personal reasons.
Seventy-four participants were included in the ﬁnal analysis. The
study consisted of 74 participants who were on antihypertensive
medications (28.4%), lipid-lowering medications (20.3%), and
antidiabetic medications (13.5%). Treatments remained unchanged
during the intervention. No instructions on eating habits or nutri-
tion were provided, and no dietary intervention was administered.
Before and at the end of the 12-week intervention, functional tests
and metabolic proﬁles were measured.
2.4. Six-minute walking distance
The 6-minute walking test (6MWT) measures the distance an
individual is able to walk over a total of 6 minutes on a hard, ﬂat
surface, at baseline and at 12 weeks. The goal is for the individual to
walk as far as possible in 6 minutes. The individual is allowed to
self-pace and rest as needed, as they traverse back and forth along a
marked walkway.15
2.5. Statistical analysis
Data are presented as themean± standard deviation (SD) unless
otherwise speciﬁed, and in the cases of parameters with non-
normal distributions (TG, FPG, hsCRP, IRI, and HOMA-IR), the data
are shown as median (interquartile range) values. In all analyses,
parameters with non-normal distributions were used after log-
transformation. Statistical analysis was performed using IBM SPSS
Statistics Version 21 (Statistical Package for Social Science Japan,
Inc., Tokyo, Japan). Twelve-week changes in various factors and 6-
minute walking distance (6MWD) were calculated by subtracting
the 12-week values from the baseline values. Differences among
pre- and post-training were analyzed by paired t test. Pearson's
correlation and multiple linear regression analysis were used to
estimate baseline factors on HOMA-IR, and changes in their vari-
ables on HOMA-IR. The synergistic effect of baseline factors and
changes in 6MWD on changes in HOMA-IR was evaluated using a
general linear model. A p value < 0.05 was considered signiﬁcant.
3. Results
Baseline characteristics for participants are shown in Table 1.
Participants had a mean age of 68 years (SD, 7 years; range, 53e86
years) and a mean BMI of 24.0 kg/m2 (3.0 kg/m2; range,
Table 1
Characteristics of participants.
Characteristics N ¼ 74 Pre-data Post-data p*
Body mass indexa (kg/m2) 24.0 ± 3.0 23.1 ± 2.7 <0.001
Waist circumference (cm) 84.9 ± 8.9 82.5 ± 7.6 <0.001
Systolic blood pressure (mmHg) 144 ± 26 134 ± 19 <0.001
Diastolic blood pressure (mmHg) 77 ± 12 74 ± 13 0.013
Triglycerides (mg/dL) 90 (68e117) 96 (66e116) 0.792
HDL cholesterol (mg/dL) 69 ± 13 67 ± 14 0.026
LDL cholesterol (mg/dL) 132 ± 29 130 ± 31 0.510
High sensitivity CRP (mg/dL) 0.040 (0.020e0.090) 0.030 (0.020e0.073) 0.026
Gamma-glutamyl transferase (IU/L) 16 (12e22) 16 (12e23) 0.337
Uric acid (mg/dL) 4.8 ± 1.0 4.8 ± 1.0 0.775
Hemoglobin A1c (%) 5.7 ± 0.7 5.6 ± 0.5 0.062
Hemoglobin (g/dL) 12.9 ± 0.8 12.6 ± 0.8 <0.001
Fasting plasma glucose (mg/dL) 102 (95e112) 103 (95e107) 0.129
Immunoreactive insulin (mU/mL) 4.40 (3.40-6.85) 4.00 (2.95e5.65) 0.027
6-min walk distance (m) 552 ± 67 573 ± 84 <0.001
Data are presented as mean ± standard deviation or median (interquartile range), and are log-transformed for analysis.
CRP¼ C-reactive protein; HDL ¼ high-density lipoprotein; HOMA-IR ¼ homeostasis of model assessment of insulin resistance; LDL ¼ low-density lipoprotein.
a Body mass index was calculated using weight (kg) divided by the square of the height (m).
* Paired t test.
Pre-training Post-training
Fig. 2. HOMA-IR (homeostasis of minimal assessment of insulin resistance) before and
after the 12-week Nordic walking training program. Values represent the median (inter-
quartile range) values for 74 participants. Post-training data {2.01 (1.31e2.59)} showed
signiﬁcant reductions comparedwith the pretraining data {1.32 (0.86e2.08)} (p¼ 0.022).
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tors, and baseline BMI, waist circumference, systolic blood pressure
(SBP), LDL-C, HbA1c, and FPGwere all at the high end of the normal
range.
After the 12-week Nordic walk training program, the 6MWD
improved signiﬁcantly (p < 0.001), and BMI, waist circumference,
SBP, and diastolic blood pressure (DBP), HDL-C, hsCRP, hemoglobin,
and IRI also decreased signiﬁcantly, while TG, LDL-C, GGT, uric acid,
HbA1c, and FPG were unchanged (Table 1).
As shown in Table 2, baseline BMI (r ¼ 0.548, p < 0.001), waist
circumference (r ¼ 0.485, p < 0.001), DBP (r ¼ 0.322, p ¼ 0.005), TG
(r ¼ 0.320, p ¼ 0.006), HDL-C (r ¼ 0.295, p ¼ 0.011), GGT
(r ¼ 0.475, p < 0.001), and Hb (r ¼ 0.230, p ¼ 0.049) correlated
signiﬁcantly with the measurements of the baseline HOMA-IR.
Stepwise multiple linear regression analyses for HOMA-IR
showed that the baseline BMI (b ¼ 0.467, p < 0.001), hsCRP
(b ¼ 0.279, p ¼ 0.004), and GGT (b ¼ 0.414, p < 0.001) were
independently and signiﬁcantly associated with the baseline
HOMA-IR, and their factors explained 44.3% of the variance in the
predicted HOMA-IR.
As shown in Fig. 2, baseline HOMA-IR improved signiﬁcantly
from a median (interquartile range) of 2.01 (1.31e2.59) to 1.32Table 2
Relationship between baseline characteristics and HOMA-IR.
Characteristics N ¼ 74 r (p)
Age (y) 0.195 (0.096)
Body mass index 0.548 (<0.001)
Waist circumference 0.485 (<0.001)
Systolic blood pressure 0.152 (0.196)
Diastolic blood pressure 0.322 (0.005)
Triglycerides 0.320 (0.006)
HDL cholesterol 0.295 (0.011)
LDL cholesterol 0.040 (0.734)
High sensitivity CRP 0.004 (0.974)
Gamma- glutamyl transferase 0.475 (<0.001)
Uric acid 0.228 (0.050)
Hemoglobin A1c 0.044 (0.710)
Hemoglobin 0.230 (0.049)
6-minute walk distance 0.114 (0.334)
R2 d
b ¼ standardized coefﬁcient; r ¼ Pearson's correlation coefﬁcient; CRP¼ C-reactive
assessment of insulin resistance; LDL ¼ low-density lipoprotein.
Data for HOMA-IR, triglycerides, high sensitivity CRP, and g-glutamyltransferase were
and stepwise multiple linear regression analysis were used to estimate baseline varia(0.86e2.08) after the 12-week Nordic walk training program. Re-
lationships between changes in various factors and HOMA-IR after
intervention are shown in Table 3. Changes in BMI (r ¼ 0.300,
p ¼ 0.009), TG (r ¼ 0.338, p ¼ 0.003), hsCRP (r ¼ 0.236, p ¼ 0.043),
GGT (r ¼ 0.285, p ¼ 0.014), uric acid (r ¼ 0.284, p ¼ 0.014), HbA1cForced
b (p)
Stepwise
b (p)
0.063 (0.603) d
0.289 (0.090) 0.467（<0.001）
0.050 (0.749) d
0.057 (0.693) d
0.077 (0.575) d
0.035 (0.761) d
0.167 (0.154) d
0.018 (0.853) d
0.305 (0.004) 0.279 (0.004)
0.397 (0.001) 0.414 (<0.001)
0.138 (0.177) d
0.060 (0.546) d
0.005 (0.965) d
0.007 (0.946) d
0.507 (<0.001) 0.443 (<0.001)
protein; HDL ¼ high-density lipoprotein; HOMA-IR ¼ homeostasis of model
skewed, and were log-transformed for analysis. Pearson's correlation coefﬁcient
bles on HOMA-IR.
Table 3
Relationship between changes in characteristics and changes in HOMA-IR by the 12-week Nordic walking training program.
Change in characteristics (N ¼ 74) r (p) Forced
b (p)
Stepwise
b (p)
Body mass index 0.300 (0.009) 0.184 (0.136) 0.255 (0.019)
Waist circumference 0.206 (0.078) 0.081 (0.473) d
Systolic blood pressure 0.080 (0.497) 0.122 (0.339) d
Diastolic blood pressure 0.036 (0.762) 0.113 (0.399) d
Triglycerides 0.338 (0.003) 0.269 (0.035) 0.266 (0.015)
HDL cholesterol 0.074 (0.534) 0.091 (0.489) d
LDL cholesterol 0.080 (0.496) 0.021 (0.870) d
High sensitivity CRP 0.236 (0.043) 0.142 (0.237) d
Gamma-glutamyl transferase 0.285 (0.014) 0.150 (0.176) d
Uric acid 0.284 (0.014) 0.186 (0.130) 0.279 (0.009)
Hemoglobin A1c 0.251 (0.031) 0.080 (0.516) d
Hemoglobin 0.293 (0.011) 0.058 (0.654) d
6-min walk distance 0.238 (0.041) 0.023 (0.851) d
R2 d 0.356 (0.007) 0.246 (<0.001)
b ¼ standardized coefﬁcient; r ¼ Pearson's correlation coefﬁcient.
Pearson's correlation coefﬁcient and multiple linear regression analysis were used to estimate change in characteristics on change in HOMA-IR. Change¼ post-data pre-
data.
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(r ¼ 0.238, p ¼ 0.014) correlated signiﬁcantly with the changes in
HOMA-IR. In addition, stepwise multiple linear regression analyses
for the changes in HOMA-IR showed that the changes in BMI
(b ¼ 0.255, p ¼ 0.019), TG (b ¼ 0.266, p ¼ 0.015), and uric acid
(b ¼ 0.279, p ¼ 0.009) were independently and signiﬁcantly asso-
ciated with changes in HOMA-IR, and these factors accounted for
24.6% of the variance.
Next, to control potential confounding variables by baseline BMI
and GGT which were strongly and signiﬁcantly associated with the
baseline HOMA-IR, the data was further stratiﬁed by baseline BMI
and GGT using the index of the insulin resistance acquired from
previous research, which were performed by residents of the same
town (Table 4).16,17 Changes in 6MWDwere signiﬁcantly associated
with changes in HOMA-IR in the GGT  26 IU/L groups, and there
was a signiﬁcant interaction only between the two groups for GGT
(p ¼ 0.014). However, there was no interaction between the two
groups regarding BMI.
Fig. 3 shows the relationships between the changes in 6MWD
and HOMA-IR of two groups categorized by baseline GGT. In par-
ticipants with baseline GGT 26 IU/L, increased 6MWD correlated
signiﬁcantly with changes in the HOMA-IR (r ¼ 0.682, p ¼ 0.005),
but not with those participants with baseline GGT < 26 IU/L
(r ¼ 0.127, p ¼ 0.338). Analysis of covariance showed that two
regression lines in each graph were signiﬁcantly different (F¼ 5.64,
p ¼ 0.020).
4. Discussion
The Nordic walk training program is a low cost, safe, and
effective form of exercise suitable for the elderly.18 This study
demonstrated that a 12-week structured training program hadTable 4
Association between changes in 6-minute walk distance and changes in HOMA-IR,
within selected subgroups.
Baseline characteristics n (N ¼ 74) b (p*) p-interaction
Body mass index (kg/m2)
< 23 32 0.134 (0.501) 0.978
 23 42 0.072 (0.582)
Gamma-glutamyl transferase (IU/L)
< 26 59 0.006 (0.962) 0.014
 26 15 0.586 (0.042)
b ¼ standardized coefﬁcient.
* Adjusted for change in body mass index, triglycerides, and uric acid.positive effects on the metabolic state and physical performance of
the participants. After the 12-week intervention, HOMA-IR and
6MWD improved signiﬁcantly. Changes in BMI, as well as changes
in TG and serum uric acid, were independently and signiﬁcantly
associated with changes in HOMA-IR. We further suggested that
changes in 6MWD also strongly predicted improved HOMA-IR in
participants with baseline GGT 26 IU/L.
Endurance and strength training have well-known cardiovas-
cular adaptations and lead to hypertrophy and increased capillary
density in muscles.19 At a given walking speed, Nordic walking
involves more muscles in various body segments and induces
greater exercise intensity than level walking.20 In addition, the use
of poles in Nordic walking attenuates muscle activity in the lower
extremities during the stance and push-off phases, and decreases
that of the lower extremities and increases energy expenditure of
the upper body and respiratory system at certain walking speeds.21
Compared with regular walking, Nordic walking required as much
as 67% greater energy expenditure.22 Nordic walking, examined in
the ﬁeld, results in a signiﬁcant increase in oxygen use and caloric
expenditure compared to regular walking, without signiﬁcantly
increasing perceived exertion.1 Thus, in our study we conducted
Nordic walking as a training program to determine the effects of a
12-week exercise training intervention on insulin resistance in
elderly persons.
The 6MWT is a commonly used test to estimate functional ex-
ercise capacity and the changes resulting from therapeutic inter-
vention in patients with chronic respiratory disease23 and heart
failure.24 The test has since been used as a performanceebased
measurement of functional exercise capacity in healthy elderly
persons. The 6MWD in healthy adults has been reported to range
from 400 m to 700 m.25 In our study, the mean value (± SD) of
6MWD was 552 m (±67 m) before training, and it increased
signiﬁcantly after training intervention. The changes in 6MWD
caused improvements in HOMA-IR, independent of the change in
confounding factors in participants with baseline GGT  26 IU/L.
Themechanisms of improvement in insulin resistance predicted
by the increased 6MWD as well as the decreased BMI and GGT after
training intervention, remains to be clariﬁed. However, both
elevated BMI and GGT reﬂect inﬂammation, which impairs insulin
signaling in the liver, muscle, and adipose tissues,26 and systemic
inﬂammation is closely involved in the pathogenesis of insulin
resistance.11 Moreover, recent data has suggested that serum GGT
can also be considered as a marker of oxidative stress.27 Nordic
walking improves chronic inﬂammation caused by excess body
weight, and can also prevent fatty liver in patients whose lipid and
Fig. 3. Relationship between changes in 6-minute walk distance (6MWD) and HOMA-IR (homeostasis of minimal assessment of insulin resistance) after the 12-week Nordic
walking training program of participants categorized by baseline gamma-glutamyl transferase (GGT). The increased 6MWD correlated signiﬁcantly with decreased HOMA-IR in
participants with baseline GGT 26 IU/L (solid line, r ¼ 0.682, p ¼ 0.005), but not in those with baseline GGT < 26 IU/L (broken line, r ¼ 0.127, p ¼ 0.338). Analysis of covariance
showed that two regression lines in each graph were signiﬁcantly different (F ¼ 5.64, p ¼ 0.020).
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was signiﬁcantly improved after Nordic walk training. Further-
more, one should note that a correlation of 0.7 can be reached
between increased 6MWD and improvements in HOMA-IR, espe-
cially in participants with baseline GGT  26 IU/L, which suggests
the existence of oxidative stress.28,29
Some limitations of this study must be considered. First, a 12-
week intervention may potentially be too brief for measuring the
effects of Nordic walk training. Long-term studies of similar exer-
cise intensity and frequency are warranted to elucidate whether
Nordic walking may be a sustainable mode of exercise. Secondly,
the daily physical activity of participants in our study, prior to entry
and during the study, was not controlled or matched. Thirdly,
although we have comprehensively adjusted for such confounders
as gender, age, markers of inﬂammation (e.g., hsCRP), GGT, and uric
acid, in the association of 6MWD and insulin resistance, other
important measures such as cognitive ability, symptoms of
depression, or markers of endothelial dysfunction were absent.
Therefore the demographics and referral source may limit
generalizing.
In conclusion, the present study showed that the increased
6MWD induced by Nordic walk training in participants with mildly
elevated GGTmay predict improvements in their insulin resistance.Conﬂicts of interest
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